Source:http://linkedlifedata.com/resource/pubmed/id/15638387
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2005-1-10
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:volume |
49 Suppl 1
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
94-7
|
| pubmed:dateRevised |
2006-1-6
|
| pubmed:meshHeading |
pubmed-meshheading:15638387-Brain Neoplasms,
pubmed-meshheading:15638387-Drug Carriers,
pubmed-meshheading:15638387-Gene Therapy,
pubmed-meshheading:15638387-Humans,
pubmed-meshheading:15638387-Liposomes,
pubmed-meshheading:15638387-Neuroblastoma,
pubmed-meshheading:15638387-Oligonucleotides, Antisense
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Antisense strategy in malignant brain tumours treatment.
|
| pubmed:affiliation |
School of Medicine, Case Western Reserve University, Cleveland, USA.
|
| pubmed:publicationType |
Journal Article
|